MyHealthchecked (MHC)

Sector:

Health Care

Index:

FTSE AIM All-Share

9.75p
   
  • Change Today:
    -0.25p
  • 52 Week High: 27.00
  • 52 Week Low: 8.50
  • Currency: UK Pounds
  • Shares Issued: 52.01m
  • Volume: 5,128
  • Market Cap: £5.07m
  • RiskGrade: 796
  • Beta: 0.03

Concepta launching 'myLotus' fertility product in London

By Josh White

Date: Wednesday 31 Oct 2018

LONDON (ShareCast) - (Sharecast News) - Concepta announced the launch of its 'myLotus' product for women's fertility at the Fertility Show in London on the weekend of 3-4 November on Wednesday.
The AIM-traded firm said myLotus allowed women to self-test to identify their optimal fertile days, improving their chances of naturally getting pregnant.

It said myLotus enabled women to monitor their fertile phase as part of their menstrual cycle, and was the only home test to "quantitatively" measure personalised hormone levels and the "rate-of-change" of those levels preceding ovulation, to help aid a natural conception.

Users measured, recorded and tracked their hormone levels, and followed their fertility journey in an accompanying app.

Concepta said myLotus would be available to women who were planning to start a family, or for those who had previously struggled to naturally conceive, enabling couples an alternative prior to considering more costly IVF treatment.

The Fertility Show stand would also include representation from "key opinion leaders", fertility doctors and health experts, who would be available to discuss myLotus.

"The Fertility Show marks the UK launch of our myLotus fertility product and the start of our roll-out across CE territories," said Concepta chairman Matthew Walls.

"We look forward to an exciting Fertility Show and to welcoming women and couples to our stand."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

MHC Market Data

Currency UK Pounds
Share Price 9.75p
Change Today -0.25p
% Change -2.50 %
52 Week High 27.00
52 Week Low 8.50
Volume 5,128
Shares Issued 52.01m
Market Cap £5.07m
Beta 0.03
RiskGrade 796

MHC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.78% above the market average90.78% above the market average90.78% above the market average90.78% above the market average90.78% above the market average
93.75% above the sector average93.75% above the sector average93.75% above the sector average93.75% above the sector average93.75% above the sector average
Price Trend
73.76% below the market average73.76% below the market average73.76% below the market average73.76% below the market average73.76% below the market average
13.51% below the sector average13.51% below the sector average13.51% below the sector average13.51% below the sector average13.51% below the sector average
Income Not Available
Growth
30.07% below the market average30.07% below the market average30.07% below the market average30.07% below the market average30.07% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average

MHC Dividends

No dividends found

Trades for 01-May-2024

Time Volume / Share Price
09:39 71 @ 10.50p
09:39 286 @ 9.50p
08:18 4,771 @ 10.40p

MHC Key Personnel

CEO Penelope McCormick
CFO Lesley Innes

Top of Page